-- 
SWISS DAYBOOK: Givaudan Third-Quarter Sales, Kuehne & Nagel

-- B y   E l e n a   L o g u t e n k o v a   a n d   C o r i n n e   G r e t l e r
-- 
2011-10-11T05:58:11Z

-- http://www.bloomberg.com/news/2011-10-11/swiss-daybook-givaudan-third-quarter-sales-kuehne-nagel.html
Givaudan SA, the maker of the
fragrances for  Marc Jacobs ’s Lola and Paco Rabanne’s 1 Million,
reported third-quarter sales that missed analysts’ estimates,
weighed down by gains in the Swiss franc.  Sales dropped 11 percent to 966 million francs ($1.07
billion) from 1.08 billion francs a year earlier, Vernier,
Switzerland-based Givaudan said today in an e-mailed statement.
Analysts had predicted 983.8 million francs, according to six
estimates in a Bloomberg survey.  EQUITIES:
*Kuehne & Nagel AG agreed to buy Carl Drude GmbH & Co. KG for an
undisclosed amount
*Roche and Morphosys AG’s experimental Alzheimer’s treatment
gantenerumab appeared to reduce the build-up in the brain of
beta amyloid plaque thought to be linked to the disease,
according to a study
*Lonza enters a partnership with Lipogen for the exclusive
rights to sell phosphatidylserine (PS) and PS-based formulations
in dietary supplements, medical foods, and food and beverages
under the Lonza name
*Actelion was raised to “buy” at Jefferies  ECONOMY/POLITICS:
*SNB announces federal  bond issue , 8 a.m.
*SNB announces federal bond issue results, 11:30 a.m.  MARKETS:
*The SMI rose 1.2 percent to 5,718.56.
*The SPI increased 1.1 percent to 5,169.36.
*The Stoxx Europe 600 Index gained 1.7 percent to 235.94.
*The MSCI Asia-Pacific Index rose 2.1 percent at 7:39 a.m.
Zurich time
*Euro-franc traded at 1.2337 at 7:39 a.m. in Zurich  To contact the reporters on this story:
Elena Logutenkova in Zurich at 
 elogutenkova@bloomberg.net ;
Corinne Gretler in Zurich at 
 cgretler1@bloomberg.net   To contact the editor responsible for this story:
Angela Cullen at 
 acullen8@bloomberg.net  